Dataset Information

Forced Expiratory Flow (FEF_25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.

ABSTRACT:

Introduction

In pediatric patients with asthma, measurements of forced expiratory volume in 1 s (FEV₁) may be normal or may not correlate with symptom severity. Forced expiratory flow at 25-75% of the vital capacity (FEF_25-75%) is a potentially more sensitive parameter for assessing peripheral airway function. This post hoc analysis compared FEF_25-75% with FEV₁ as an endpoint to assess bronchodilator responsiveness in children with asthma.

Methods

Change from baseline in trough FEF_25-75% and trough FEV₁ following treatment with either tiotropium (5 µg or 2.5 µg) or placebo Respimat^® was analyzed in four phase III trials in children (aged 6-11 years) and adolescents (aged 12-17 years) with symptomatic moderate (VivaTinA-asthma^® and PensieTinA-asthma^®) and mild (CanoTinA-asthma^® and RubaTinA-asthma^®) asthma. Data from all treatment arms were pooled and correlations between FEF_25-75% and FEV₁ were calculated and analyzed.

Results

A total of 1590 patients were included in the analysis. Tiotropium Respimat^® consistently improved FEF_25-75% and FEV₁ versus placebo, although in adolescents with severe asthma, the observed improvements were not statistically significant. Improvements in FEF_25-75% response with tiotropium versus placebo were largely more pronounced than improvements in FEV₁. Statistical assessment of the correlation of FEV₁ and FEF_25-75% showed moderate-to-high correlations (Pearson's correlation coefficients 0.73-0.80).

Conclusions

In pediatric patients, FEF_25-75% may be a more sensitive measure to detect treatment response, certainly to tiotropium, than FEV₁ and should be evaluated as an additional lung function measurement.

SUBMITTER: Szefler SJ

PROVIDER: S-EPMC7672130 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Forced Expiratory Flow (FEF<sub>25-75%</sub>) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.

Szefler Stanley J SJ Goldstein Stanley S Vogelberg Christian C Bensch George W GW Given John J Jugovic Branko B Engel Michael M Moroni-Zentgraf Petra M PM Sigmund Ralf R Hamelmann Eckard H EH

Pulmonary therapy 20200512 2

<h4>Introduction</h4>In pediatric patients with asthma, measurements of forced expiratory volume in 1 s (FEV<sub>1</sub>) may be normal or may not correlate with symptom severity. Forced expiratory flow at 25-75% of the vital capacity (FEF<sub>25-75%</sub>) is a potentially more sensitive parameter for assessing peripheral airway function. This post hoc analysis compared FEF<sub>25-75%</sub> with FEV<sub>1</sub> as an endpoint to assess bronchodilator responsiveness in children with asthma.<h4>M ...[more]

PMID: 32399899

Similar Datasets

Project description:ObjectivesThe aim of this study was to assess the prevalence and determinants of post-tuberculosis chronic respiratory signs, as well as the clinical impact of a low forced expiratory flow between 25% and 75% (FEF25-75%) in a group of individuals previously treated successfully for pulmonary tuberculosis.DesignThis was a cross-sectional study involving individuals in their post-tuberculosis treatment period. They all underwent a spirometry following the 2005 criteria of the American Thoracic Society/European Respiratory Society. Distal airflow obstruction (DAO) was defined by an FEF25-75% <65% and a ratio forced expiratory volume during the first second (FEV1)/forced vital capacity (FVC) ≥ 0.70. Logistic regression models were used to investigate the determinants of persisting respiratory symptoms following antituberculous treatment.SettingThis study was carried out in the tuberculosis diagnosis and treatment centre at Yaounde Jamot Hospital, which serves as a referral centre for tuberculosis and respiratory diseases for the capital city of Cameroon (Yaounde) and surrounding areas.ParticipantsAll consecutive patients in their post-tuberculosis treatment period were consecutively enrolled between November 2012 and April 2013.ResultsOf the 177 patients included, 101 (57.1%) were men, whose median age (25th-75th centiles) was 32 (24-45.5) years. At least one chronic respiratory sign was present in 110 (62.1%) participants and DAO was found in 67 (62.9%). Independent determinants of persisting respiratory signs were the duration of symptoms prior to tuberculosis diagnosis higher than 12 weeks (adjusted OR 2.91; 95% CI 1.12 to 7.60, p=0.029) and presence of DAO (2.22; 1.13 to 4.38, p=0.021).ConclusionsFEF25-75%<65% is useful for the assessment and diagnosis of post-tuberculous DAO. Mass education targeting early diagnosis of pulmonary tuberculosis can potentially reduce the prevalence of post-tuberculosis respiratory signs and distal airflow obstruction.

Project description:BackgroundThe assumption that the assessment of forced expiratory flow between 25% and 75% of vital capacity (FEF(25-75)) does not provide additional information in asthmatic children with normal FEV(1) percent predicted has not been adequately tested.ObjectiveWe sought to determine whether the measurement of FEF(25-75) percent predicted offers advantages over FEV(1) percent predicted and FEV(1)/forced vital capacity (FVC) percent predicted for the evaluation of childhood asthma.MethodsThis is a secondary analysis of data from the Pediatric Asthma Controller Trial and the Characterizing the Response to a Leukotriene Receptor Antagonist and Inhaled Corticosteroid trials. Pearson correlation coefficients, Pearson partial correlation coefficients, canonical correlations, and receiver operating characteristic (ROC) curves were constructed.ResultsAmong 437 children with normal FEV(1) percent predicted, FEF(25-75) percent predicted, and FEV(1)/FVC percent predicted were (1) positively correlated with log(2) methacholine PC(20), (2) positively correlated with morning and evening peak expiratory flow percent predicted, and (3) negatively correlated with log(10) fraction of exhaled nitric oxide and bronchodilator responsiveness. Pearson partial correlations and canonical correlations indicated that FEF(25-75) percent predicted was better correlated with bronchodilator responsiveness and log(2) methacholine PC(20) than were FEV(1) percent predicted or FEV(1)/FVC percent predicted. In the ROC curve analysis, FEF(25-75) at 65% of predicted value had a 90% sensitivity and a 67% specificity for detecting a 20% increase in FEV(1) after albuterol inhalation.ConclusionFEF(25-75) percent predicted was well correlated with bronchodilator responsiveness in asthmatic children with normal FEV(1). FEF(25-75) percent predicted should be evaluated in clinical studies of asthma in children and might be of use in predicting the presence of clinically relevant reversible airflow obstruction.

Dataset Information

Forced Expiratory Flow (FEF_25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.

Introduction

Methods

Results

Conclusions

Publications

Forced Expiratory Flow (FEF<sub>25-75%</sub>) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Dataset Information

Forced Expiratory Flow (FEF25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.

Introduction

Methods

Results

Conclusions

Publications

Forced Expiratory Flow (FEF<sub>25-75%</sub>) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Forced Expiratory Flow (FEF_25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.